Cornerstone Advisors (Washington)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,163
| Closed | -$100K | – | 907 |
|
|
2019
Q2 | $100K | Buy |
1,163
+45
| +4% | +$3.87K | 0.01% | 248 |
|
|
2019
Q1 | $99K | Buy |
1,118
+62
| +6% | +$5.49K | 0.01% | 232 |
|
|
2018
Q4 | $90K | Sell |
1,056
-2
| -0.2% | -$170 | 0.02% | 202 |
|
|
2018
Q3 | $103K | Hold |
1,058
| – | – | 0.07% | 208 |
|
|
2018
Q2 | $100K | Sell |
1,058
-69
| -6% | -$6.52K | 0.07% | 201 |
|
|
2018
Q1 | $91K | Hold |
1,127
| – | – | 0.06% | 204 |
|
|
2017
Q4 | $100K | Sell |
1,127
-219
| -16% | -$19.4K | 0.07% | 187 |
|
|
2017
Q3 | $125K | Sell |
1,346
-4
| -0.3% | -$371 | 0.09% | 167 |
|
|
2017
Q2 | $123K | Sell |
1,350
-25
| -2% | -$2.28K | 0.07% | 159 |
|
|
2017
Q1 | $121K | Buy |
1,375
+4
| +0.3% | +$352 | 0.07% | 163 |
|
|
2016
Q4 | $114K | Buy |
1,371
+212
| +18% | +$17.6K | 0.1% | 158 |
|
|
2016
Q3 | $107K | Buy |
1,159
+209
| +22% | +$19.3K | 0.09% | 166 |
|
|
2016
Q2 | $74K | Buy |
950
+13
| +1% | +$1.01K | 0.08% | 125 |
|
|
2016
Q1 | $77K | Buy |
937
+104
| +12% | +$8.55K | 0.08% | 128 |
|
|
2015
Q4 | $87K | Sell |
833
-960
| -54% | -$100K | 0.1% | 128 |
|
|
2015
Q3 | $189K | Sell |
1,793
-275
| -13% | -$29K | 0.17% | 99 |
|
|
2015
Q2 | $283K | Hold |
2,068
| – | – | 0.23% | 72 |
|
|
2015
Q1 | $258K | Hold |
2,068
| – | – | 0.2% | 86 |
|
|
2014
Q4 | $187K | Buy |
+2,068
| New | +$187K | 0.14% | 116 |
|